@article{026b7914837847d799b207f7f4ddc731,
title = "IsMini-dose Glucagon the answer to preventing exercise-related dysglycemia?",
author = "Castle, {Jessica R.}",
note = "Funding Information: Duality of Interest. J.R.C. has a financial interest in Pacific Diabetes Technologies, Inc., a company that may have a commercial interest in the results of this type of research and technology. This potential conflict of interest has been reviewed and managed by Oregon Health & Science University. J.R.C. also has received research funding from Xeris Pharmaceuticals and consulting fees from Zealand Pharma. No other potential conflicts of interest relevant to this article were reported.",
year = "2018",
month = sep,
day = "1",
doi = "10.2337/dci18-0024",
language = "English (US)",
volume = "41",
pages = "1842--1843",
journal = "Diabetes care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "9",
}